Business
Up 300% in 1 year, what’s driving the Incannex Healthcare (ASX:IHL) share price?

The Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, has remained relatively flat in today’s trade.
We take a look at the ASX healthcare share’s latest announcement on its accelerated drug study, along with its share price performance over the past year.
What did Incannex Healthcare report?
Incannex Healthcare shares are flat today after the company reported it has partnered with Monash Trauma Group to study the effectiveness of its proprietary drug on treating concussions.
The in vivo study, to be conducted on rats, will assess the “neuroprotective capability of…
-
General20 hours ago
California worker dead and hundreds arrested after cannabis farm raid
-
Noosa News19 hours ago
Unlawful wounding charges, Caloundra – Sunshine Coast
-
General12 hours ago
West Indies-Australia live: Third day-night Test in Jamaica
-
Business11 hours ago
This artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025